Immunotherapy in lung cancer

被引:18
作者
Al-Moundhri, M
O'Brien', M
Souberbielle, BE
机构
[1] Royal Marsden Hosp, Lung Unit, Sutton SM2 5PT, Surrey, England
[2] Kings Coll, Sch Med, London SE5 5NU, England
关键词
immunotherapy; lung cancer; BCG; vaccine;
D O I
10.1038/bjc.1998.486
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
More research and new treatment options are needed in all stages of lung cancer. To this end immunotherapy needs a revival in view of recent improved technologies and greater understanding of the underlying biology. In this review we discuss mechanisms of tumour immunotherapy, non-specific, specific and adoptive, with particular reference to a direct therapeutic action on all subtypes of lung cancer.
引用
收藏
页码:282 / 288
页数:7
相关论文
共 89 条
[1]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[2]  
AMERY WK, 1978, CANCER TREAT REP, V62, P1677
[3]   LEVAMISOLE AND SURGERY IN BRONCHIAL-CARCINOMA PATIENTS - INCREASE IN DEATHS FROM CARDIORESPIRATORY FAILURE [J].
ANTHONY, HM ;
MEARNS, AJ ;
MASON, MK ;
SCOTT, DG ;
MOGHISSI, K ;
DEVERALL, PB ;
ROZYCKI, ZJ ;
WATSON, DA .
THORAX, 1979, 34 (01) :4-12
[4]  
ARDIZZONI A, 1994, CANCER, V73, P1353, DOI 10.1002/1097-0142(19940301)73:5<1353::AID-CNCR2820730508>3.0.CO
[5]  
2-H
[6]   MITOMYCIN-IFOSFAMIDE-CISPLATINUM (MIP) VS MIP-INTERFERON VS CISPLATINUM-CARBOPLATIN IN METASTATIC NON-SMALL-CELL LUNG-CANCER - A FONICAP RANDOMIZED PHASE-II STUDY [J].
ARDIZZONI, A ;
ADDAMO, GF ;
BALDINI, E ;
BORGHINI, U ;
PORTALONE, L ;
DEMARINIS, F ;
LIONETTO, R ;
CONTE, PF ;
BRUZZI, P ;
PENNUCCI, MC ;
VENTURINI, M ;
RINALDI, M ;
ROSSO, R ;
SALVATI, F .
BRITISH JOURNAL OF CANCER, 1995, 71 (01) :115-119
[7]  
ARDIZZONI A, 1993, CANCER-AM CANCER SOC, V72, P2929, DOI 10.1002/1097-0142(19931115)72:10<2929::AID-CNCR2820721012>3.0.CO
[8]  
2-X
[9]  
BERNSTEIN Z, 1989, P AN M AM SOC CLIN, V8, pA754
[10]   Tumor antigens recognized by T cells [J].
Boon, T ;
Coulie, PG ;
VandenEynde, B .
IMMUNOLOGY TODAY, 1997, 18 (06) :267-268